Psilocybin-assisted group therapy might help reduce depression in cancer patients. This innovative approach, blending psychedelic effects with psychological support, has demonstrated promising results in improving mental health and quality of life for these patients.
Scientists at Enveric Biosciences have created novel psilocybin derivatives, potentially offering therapeutic mental health benefits with reduced psychedelic effects. This research paves the way for new treatments for depression and anxiety.
Research from Toronto Western Hospital shows psilocybin-assisted psychotherapy as a promising treatment for major depression and cancer-related distress, calling for urgent advanced clinical trials. This innovative approach combines psychedelic mushrooms with guided therapy, offering new hope in mental health.
New research suggests a single dose of psilocybin, combined with psychotherapy, could significantly reduce depression in individuals with bipolar II disorder, maintaining these effects for 12 weeks. This innovative approach, contrasting sharply with self-medication, highlights the potential of controlled psychedelic...
A new study has found a link between psilocybin use and lowered psychological distress, particularly in individuals with adverse childhood experiences, highlighting the possible therapeutic applications of psychedelics.
New research in the Journal of Humanistic Psychology found that individuals who've used psilocybin have strong antidepressant expectations, especially those with profound experiences like emotional breakthroughs. However, they expect less impact on motivation and sleep disturbances. The study emphasizes the...
A recent multi-site study published in the Journal of the American Medical Association revealed that psilocybin-assisted therapy offers rapid and sustained antidepressant effects for individuals with major depressive disorder. Compared to an active placebo, the treatment improved psychosocial functioning and...
A recent scientific study has uncovered an intriguing connection between the use of psilocybin, the psychoactive compound found in certain "magic" mushrooms, and reduced overtime work among full-time employees. While the study's findings aren't conclusive proof of causation, they shed...
In a phase II clinical trial, a single dose of psilocybin, combined with SSRI treatment and supportive therapy, showed promising safety and therapeutic outcomes for individuals with treatment-resistant depression. While the results suggest that SSRIs do not inhibit the potential...
A recent study published in the Journal of Psychopharmacology suggests that psilocybin, the active component in "magic mushrooms", can induce lasting neuroplastic changes in the brain, which are associated with improvements in symptoms of depression. The research, which found significant...
A recent study in ACS Pharmacology & Translational Science discovered that a temporary spike in stress hormones, specifically corticosterone, plays a central role in reducing anxiety-like behaviors in mice given the psychedelic substance psilocybin. The findings offer crucial insights into...
Researchers in the United Kingdom recently conducted a study to determine if psychedelic-assisted psychotherapy could be a more cost-effective option than more traditional forms of psychotherapy for those who experience depression. The results suggested that this unique approach could be...
Psilocybin has antidepressant-like effects and can improve cognitive function in a rat model of depression induced by chronic stress, according to new research published in Psychedelic Medicine. The findings provide new insights into the potential therapeutic applications of psychedelic substances...
A study published in the Journal of Affective Disorders reveals that psilocybin-assisted therapy reduces experiential avoidance, leading to improved well-being and decreased depression, anxiety, and suicidal thoughts in depressed patients. The research highlights the significance of experiential avoidance as a...
A new study suggests that psilocybin-assisted group therapy is a promising approach for cancer patients dealing with depressive symptoms. The research, which appears in the Journal of Pain and Symptom Management, provides initial evidence of the safety, feasibility, and possible...